LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 4.24 | 21.74 | 10 | 317 | 0.0315 | -0.1818 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 4.24 | 21.74 | 802 | 317 | 2.5237 | 1.5405 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 6.21 | 21.74 | 740 | 392 | 1.8878 | 1.3290 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 6.21 | 21.74 | 15 | 392 | 0.0383 | -0.0851 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 6.21 | 21.74 | 936 | 392 | 2.3878 | 1.4639 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 8.19 | 21.74 | 1 | 439 | 0.0023 | -0.5082 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 8.19 | 21.74 | 797 | 439 | 1.8120 | 1.2937 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 8.19 | 21.74 | 23 | 439 | 0.0523 | 0.0131 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 8.19 | 21.74 | 1036 | 439 | 2.3553 | 1.4366 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 10.16 | 21.74 | 1 | 463 | 0.0022 | -0.5022 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 10.16 | 21.74 | 847 | 463 | 1.8268 | 1.2925 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 10.16 | 21.74 | 44 | 463 | 0.0949 | 0.1732 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 10.16 | 21.74 | 1081 | 463 | 2.3315 | 1.4227 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 12.13 | 21.74 | 1 | 496 | 0.0020 | -0.4945 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 12.13 | 21.74 | 894 | 496 | 1.8011 | 1.2785 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 12.13 | 21.74 | 48 | 496 | 0.0967 | 0.1919 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 12.13 | 21.74 | 1108 | 496 | 2.2323 | 1.3895 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 14.10 | 21.74 | 1 | 540 | 0.0018 | -0.4852 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 14.10 | 21.74 | 917 | 540 | 1.6952 | 1.2411 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 14.10 | 21.74 | 81 | 540 | 0.1497 | 0.3280 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 14.10 | 21.74 | 1162 | 540 | 2.1482 | 1.3585 | MN20160310_N01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 16.07 | 21.74 | 1 | 597 | 0.0017 | -0.4748 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 16.07 | 21.74 | 953 | 597 | 1.5940 | 1.2049 | MN20160310_N01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 16.07 | 21.74 | 124 | 597 | 0.2074 | 0.4393 | MN20160310_N01 | M06 |